Pharmacists in Newcastle, WY Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Tarah D Parsons, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1653 Sage St, Newcastle, WY 82701 Phone: 307-534-5724 |
 Dr. Michael Dean Cookston, PHARMD, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Boyd Ave, Newcastle, WY 82701 Phone: 307-746-2741 Fax: 307-746-9405 |
Dr. Lisa Joy Ohnstad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1124 Washington Blvd, Newcastle, WY 82701 Phone: 307-746-3721 |
Sara Butts Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Boyd Ave, Newcastle, WY 82701 Phone: 307-746-2741 |
Erica Ann Turechek, RPH Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 1124 Washington Blvd, Newcastle, WY 82701 Phone: 307-746-2425 |
Mr. Monte William Straley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 727 A Washington Blvd, Newcastle, WY 82701 Phone: 307-746-2425 Fax: 307-746-3724 |
Ruth L Taylor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 Washington Blvd, Newcastle, WY 82701 Phone: 307-746-9191 Fax: 307-746-9118 |
News Archive
Cedric – the Tasmanian devil - dies of facial tumors
Cedric, a captive born Tasmanian devil climbed to fame in 2007 when it was shown that he was genetically resistant to facial tumors. Initially he and his half-brother Clinky were given a vaccine of sorts containing dead tumor cells and later "challenged" with live tumor cells by the University of Tasmania researchers in 2007. Clinky developed the cancer, but Cedric did not - starting hopes that he had an immunity that could help scientists develop a vaccine.
New calculators could enable clinicians to better stratify risk in COVID-infected patients
Two novel calculators for predicting which patients admitted to the hospital with COVID-19 are at greatest risk of requiring mechanical ventilation or of in-hospital death have been developed and validated by Massachusetts General Hospital (MGH).
New portable shield prevents spread of saliva and aerosols generated during dental procedures
Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a high risk of exposure to COVID-19, and other critical infectious diseases.
Celladon's Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.
› Verified 9 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Clinical Social Workers
Psychologists